For solid organ transplant recipients the risk of skin cancer is markedly increased due to immunosuppression. Many studies propose an annual, or more frequent, skin screening program by a dermatologist. As the number of transplant recipients increases and survival times improve, the need for screening and rapid response (as required) access is increasing. Design In a quality control study we retrospectively examined the medical records of patients participating in an annual screening program between 1997 and 2012. A total of 69 medical records were studied and we here describe the program and present the findings. Results We found malignant melanoma in 3 cases. Cutaneous squamous cell carcinoma occurred in 16 patients and basal cell carcinoma in 12 patients. The most frequent skin lesions were actinic keratoses, reported in 20 patients. Conclusions Incidence rates for all diagnoses were elevated compared to the general population. Awareness of the increased risk for skin malignancies is of importance to those involved in the care of solid organ transplant recipients. Routines for early discovery of skin tumors are needed both in the form of screening, which can also establish risk group status and give preventive education, and as rapid response access for skin lesion diagnosis and treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.